Your request to link to MMDB for cGMP-dependent protein kinase 2 [41-418,G232E]
MMDB Description | |
---|---|
7878 | Hiv-1 Protease Complexed With a Tripeptide Inhibitor |
73437 | Hiv-1 Protease in Complex With Sdz283-910 |
73438 | Crystallographic Analysis of Human Immunodeficiency Virus 1 Protease With an Analog of the Conserved Ca-p2 Substrate: Interactions With Frequently Occurring Glutamic Acid Residue at P2' Position of Substrates |
73440 | Structural Basis for Specificity of Retroviral Proteases |
8033 | G48h Mutant of Hiv-1 Protease in Complex With a Peptidic Inhibitor U-89360e |
158 | Hydroxyethylene Isostere Inhibitors of Human Immunodeficiency Virus-1 Protease: Structure-activity Analysis Using Enzyme Kinetics, X-ray Crystallography, and Infected T-cell Assays |
6725 | Structure of a Non-peptide Inhibitor Complexed With Hiv-1 Protease: Developing a Cycle of Structure-based Drug Design |
6331 | Hiv-1 Protease in Complex With the Cyclic Sulfamide Inhibitor Aha006 |
6457 | Hiv-1 Protease in Complex With the Cyclic Urea Inhibitor Aha001 |
7498 | Active-site Mobility in Human Immunodeficiency Virus Type 1 Protease as Demonstrated by Crystal Structure of A28s Mutant |
12486 | Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic Inhibitor 1 |
12487 | Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic Inhibitor 5 |
76952 | Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic Inhibitor 4 |
12489 | Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic Inhibitor 6 |
12492 | Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic Inhibitor 7 |
8354 | Hiv-1 (2:31-37) Protease Complexed With Inhibitor Sb203386 |
8355 | Hiv-1 (2:31-37, 47, 82) Protease Complexed With Inhibitor Sb203386 |
8848 | Hiv-1 (2: 31, 33-37) Protease Complexed With Inhibitor Sb203386 |
12513 | Counteracting Hiv-1 Protease Drug Resistance: Structural Analysis of Mutant Proteases Complexed With Xv638 and Sd146, Cyclic Urea Amides With Broad Specificities |
12526 | Hiv-1 Protease (I84v) Complexed With Xv638 of Dupont Pharmaceuticals |
4873 | Hiv-1 Protease-dmp323 Complex in Solution, NMR, 28 Structures |
4872 | Hiv-1 Protease-dmp323 Complex in Solution, NMR Minimized Average Structure |
12528 | Hiv-1 Protease (V82fi84v) Double Mutant Complexed With Xv638 of Dupont Pharmaceuticals |
12529 | Hiv-1 Protease (V82fi84v) Double Mutant Complexed With Sd146 of Dupont Pharmaceuticals |
14951 | Alternate Binding Site for the P1-p3 Group of a Class of Potent Hiv-1 Protease Inhibitors as a Result of Concerted Structural Change in 80's Loop |
14952 | Alternate Binding Site for the P1-p3 Group of a Class of Potent Hiv-1 Protease Inhibitors as a Result of Concerted Structural Change in 80's Loop |
14953 | Alternate Binding Site for the P1-p3 Group of a Class of Potent Hiv-1 Protease Inhibitors as a Result of Concerted Structural Change in 80's Loop |
14954 | Alternate Binding Site for the P1-p3 Group of a Class of Potent Hiv-1 Protease Inhibitors as a Result of Concerted Structural Change in 80's Loop |
75373 | Regioselective Structural and Functional Mimicry of Peptides. Design of Hydrolytically Stable Cyclic Peptidomimetic Inhibitors of Hiv-1 Protease |
19717 | Hiv-1 Protease in Complex With the Inhibitor Bea435 |
19718 | Hiv-1 Protease in Complex With the Inhibitor Bea425 |
19719 | Hiv-1 Protease in Complex With the Inhibitor Msl370 |
14890 | Hiv-1 Protease Complexed With a Macrocyclic Peptidomimetic Inhibitor |
14712 | Hiv-1 Protease Complexed With a Macrocyclic Peptidomimetic Inhibitor |
11409 | Hiv-1 Protease V82fi84v Double Mutanttipranavir Complex |
11395 | Hiv-1 Protease Triple Mutanttipranavir Complex |
73540 | Structural and Kinetic Analysis of Drug Resistant Mutants of Hiv-1 Protease |
4447 | Hiv-1 Protease in Complex With a Difluoroketone Containing Inhibitor A79285 |
6563 | Structure of Hiv-1 Protease Complex |
73558 | Structural and Kinetic Analysis of Drug Resistant Mutants of Hiv-1 Protease |
73567 | Structural and Kinetic Analysis of Drug Resistant Mutants of Hiv-1 Protease |
19722 | Hiv-1 Protease in Complex With the Inhibitor Bea322 |
19723 | Hiv-1 Protease in Complex With the Inhibitor Bea369 |
19724 | Hiv-1 Protease in Complex With the Inhibitor Bea388 |
19725 | Hiv-1 Protease in Complex With the Inhibitor Bea403 |
19726 | Hiv-1 Protease in Complex With the Inhibitor Bea409 |
19727 | Hiv-1 Protease in Complex With the Inhibitor Bea428 |
19728 | Hiv-1 Protease in Complex With the Inhibitor Msa367 |
16605 | HOW Does a Symmetric Dimer Recognize an Asymmetric Substrate? a Substrate Complex of Hiv-1 Protease |
15090 | Crystal Structure of an in Vivo Hiv-1 Protease Mutant in Complex With Saquinavir: Insights Into the Mechanisms of Drug Resistance |
73595 | Structural Implications of Drug Resistant Mutants of Hiv-1 Protease: High Resolution Crystal Structures of the Mutant Proteasesubstrate Analog Complexes |
73596 | Structural Implications of Drug Resistant Mutants of Hiv-1 Protease: High Resolution Crystal Structures of the Mutant Proteasesubstrate Analog Complexes |
73597 | Structural Implications of Drug Resistant Mutants of Hiv-1 Protease : High Resolution Crystal Structures of the Mutant Proteasesubstrate Analog Complexes |
73598 | Structural Implications of Drug Resistant Mutants of Hiv-1 Protease: High Resolution Crystal Structures of the Mutant Proteasesubstrate Analog Complexes |
73599 | Structural Implications of Drug Resistant Mutants of Hiv-1 Protease: High Resolution Crystal Structures of the Mutant Proteasesubstrate Analog Complexes |
73600 | Structural Implications of Drug Resistant Mutants of Hiv-1 Protease: High Resolution Crystal Structures of the Mutant Proteasesubstrate Analog Complexes |
73601 | Structural Implications of Drug Resistant Mutants of Hiv-1 Protease: High Resolution Crystal Structures of the Mutant Proteasesubstrate Analog Complexes |
73608 | Crystal Structure of the Complex of Hiv-1 Protease With a Peptidomimetic Inhibitor |
16449 | Hiv-1 Protease With Cyclic Sulfamide Inhibitor, Aha047 |
16387 | Crystal Structure of Hiv-1 Protease in Complex With Inhibitor, Aha024 |
5732 | Hiv-1 Protease Mutant With VAL 82 Replaced by ASP (V82d) Complexed With U89360e (Inhibitor) |
5733 | Hiv-1 Protease Mutant With VAL 82 Replaced by ASN (V82n) Complexed With U89360e (Inhibitor) |
5734 | Hiv-1 Protease (Wild Type) Complexed With U89360e (Inhibitor) |
3498 | a Check on Rational Drug Design. Crystal Structure of a Complex of Hiv-1 Protease With a Novel Gamma-turn Mimetic |
76639 | The Crystal Structures at 2.2 Angstroms Resolution of Hydroxyethylene-based Inhibitors Bound to Human Immunodeficiency Virus Type 1 Protease Show That the Inhibitors ARE Present in Two Distinct Orientations |
73641 | The Crystal Structures at 2.2 Angstroms Resolution of Hydroxyethylene-based Inhibitors Bound to Human Immunodeficiency Virus Type 1 Protease Show That the Inhibitors ARE Present in Two Distinct Orientations |
56338 | The Three-dimensional Structure of the Aspartyl Protease From the Hiv-1 Isolate BRU |
3495 | Comparative Analysis of the X-ray Structures of Hiv-1 and Hiv-2 Proteases in Complex With CGP 53820, a Novel Pseudosymmetric Inhibitor |
73646 | Crystal Structure of a Complex of Hiv-1 Protease With a Dihydroethylene-containing Inhibitor: Comparisons With Molecular Modeling |
1233 | Inhibition of Human Immunodeficiency Virus-1 Protease by a C2- Symmetric Phosphinate Synthesis and Crystallographic Analysis |
5809 | Hiv-1 Protease Triple Mutantu103265 Complex |
1237 | Rational Design, Synthesis and Crystallographic Analysis of a Hydroxyethylene-based Hiv-1 Protease Inhibitor Containing a Heterocyclic P1'-p2' Amide Bond Isostere |
1239 | Crystal Structure of Hiv-1 Protease in Complex With Vx-478, a Potent and Orally Bioavailable Inhibitor of the Enzyme |
4428 | Hiv-1 Protease Complexed With the Inhibitor Kni-272 |
4292 | Crystal Structure at 1.9 Angstroms Resolution of Human Immunodeficiency Virus (Hiv) II Protease Complexed With L- 735,524, an Orally Bioavailable Inhibitor of the HIV Proteases |
1260 | X-ray Crystallographic Studies of a Series of Penicillin- Derived Asymmetric Inhibitors of Hiv-1 Protease |
1261 | X-ray Crystallographic Studies of a Series of Penicillin- Derived Asymmetric Inhibitors of Hiv-1 Protease |
1262 | X-ray Crystallographic Studies of a Series of Penicillin- Derived Asymmetric Inhibitors of Hiv-1 Protease |
8945 | Nonpeptide Cyclic Cyanoguanidines as HIV Protease Inhibitors |
1281 | Influence of Stereochemistry on Activity and Binding Modes for C2 Symmetry-based Diol Inhibitors of Hiv-1 Protease |
1282 | Influence of Stereochemistry on Activity and Binding Modes for C2 Symmetry-based Diol Inhibitors of Hiv-1 Protease |
1283 | Influence of Stereochemistry on Activity and Binding Modes for C2 Symmetry-based Diol Inhibitors of Hiv-1 Protease |
1284 | Influence of Stereochemistry on Activity and Binding Modes for C2 Symmetry-based Diol Inhibitors of Hiv-1 Protease |
72319 | Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease Inhibitors |
1289 | Structural Basis of Drug Resistance for the V82a Mutant of Hiv-1 Protease: Backbone Flexibility and Subsite Repacking |
9831 | Molecular Recognition of Cyclic Urea HIV Protease Inhibitors |
49549 | Hiv-1 Proteinase Complexed With RO 31-8959 |
7007 | Hiv-1 Protease Dimer Complexed With A-84538 |
49668 | Crystal Structure of Hiv-1 Protease Complexed With a Hydroxyethylamine Peptidomimetic Inhibitor |
21361 | Inhibitor of HIV Protease With Unusual Binding Mode Potently Inhibiting Multi-resistant Protease Mutants |
21362 | Inhibitor of HIV Protease With Unusual Binding Mode Potently Inhibiting Multi-resistant Protease Mutants |
20134 | Combining Mutations in Hiv-1 Protease to Understand Mechanisms of Resistance |
20135 | Combining Mutations in Hiv-1 Protease to Understand Mechanisms of Resistance |
73738 | Combining Mutations in Hiv-1 Protease to Understand Mechanisms of Resistance |
73739 | Combining Mutations in Hiv-1 Protease to Understand Mechanisms of Resistance |
18417 | Lack of Synergy for Inhibitors Targeting a Multi-drug Resistant Hiv-1 Protease |
18418 | Lack of Synergy for Inhibitors Targeting a Multi-drug Resistant Hiv-1 Protease |
18419 | Lack of Synergy for Inhibitors Targeting a Multi-drug Resistant Hiv-1 Protease |
18420 | Lack of Synergy for Inhibitors Targeting a Multi-drug Resistant Hiv-1 Protease |
71085 | Substrate Shape Determines Specificity of Recognition Recognition for Hiv-1 Protease: Analysis of Crystal Structures of Six Substrate Complexes |
71088 | Substrate Shape Determines Specificity of Recognition Recognition for Hiv-1 Protease: Analysis of Crystal Structures of Six Substrate Complexes |
71091 | Substrate Shape Determines Specificity of Recognition Recognition for Hiv-1 Protease: Analysis of Crystal Structures of Six Substrate Complexes |
71092 | Substrate Shape Determines Specificity of Recognition Recognition for Hiv-1 Protease: Analysis of Crystal Structures of Six Substrate Complexes |
71093 | Substrate Shape Determines Specificity of Recognition Recognition for Hiv-1 Protease: Analysis of Crystal Structures of Six Substrate Complexes |
50030 | Je-2147-hiv Protease Complex |
50197 | Crystal Structure of the Complex of Mutant Hiv-1 Protease (A71v, V82t, I84v) With an Ethylenamine Peptidomimetic Inhibitor Boc-phe-psi[ch2ch2nh]-phe-glu-phe-nh2 |
50201 | Hiv-1 Protease in Complex With an Ethyleneamine Inhibitor |
7493 | Hiv-1 Mutant (I84v) Protease Complexed With Dmp450 |
7494 | Hiv-1 Mutant (I84v) Protease Complexed With Dmp323 |
7495 | Hiv-1 Mutant (V82f) Protease Complexed With Dmp323 |
7496 | Hiv-1 Mutant (V82f, I84v) Protease Complexed With Dmp323 |
24931 | Structure of HIV Protease (Mutant Q7K L33i L63i) Complexed With Kni- 577 |
24932 | Structure of HIV Protease (Mutant Q7K L33i L63i V82f I84v ) Complexed With Kni-577 |
24933 | The HIV Protease (Mutant Q7K L33i L63i) Complexed With Kni-764 (AN Inhibitor) |
24934 | The HIV Protease (Mutant Q7K L33i L63i V82f I84v) Complexed With Kni- 764 (AN Inhibitor) |
21781 | Viability of a Drug-resistant Hiv-1 Protease Mutant: Structural Insights for Better Antiviral Therapy |
21782 | Viability of a Drug-resistant Hiv-1 Protease Mutant: Structural Insights for Better Antiviral Therapy |
21783 | Viability of a Drug-resistant Hiv-1 Protease Mutant: Structural Insights for Better Antiviral Therapy |
21784 | Viability of a Drug-resistant Hiv-1 Protease Mutant: Structural Insights for Better Antiviral Therapy |
70484 | Hiv-1 Protease Complexed With a Cyclic Phe-ile-val Peptidomimetic Inhibitor |
21013 | Crystal Structure of Hiv-1 Protease Complexed With Lopinavir |
21824 | Viability of a Drug-resistant Hiv-1 Protease Variant: Structural Insights for Better Anti-viral Therapy |
50462 | 1.03 a Structure of Hiv-1 Protease: Inhibitor Binding Inside and Outside the Active Site |
26006 | Crystal Structure of Hiv-1 Protease-hup |
21903 | Crystal Structure of Hiv-1 Protease Complexed With Ldc271 |
21904 | Crystal Structure of HIV Protease Complexed With Lgz479 |
50612 | Native Hiv-1 Proteinase |
50613 | Hiv-1 Proteinase Mutant A71t, V82a |
50614 | Hiv-1 Protease Complexed With an Inhibitor Lp-130 |
9068 | Viracept (R) (Nelfinavir Mesylate, Ag1343): a Potent Orally Bioavailable Inhibitor of Hiv-1 Protease |
4836 | Hiv-1 Protease Dimer Complexed With A-98881 |
26485 | Solution Structure of the Mature Hiv-1 Protease Monomer |
6661 | Hiv-1 Protease Inhibitors Wiih LOW Nanomolar Potency |
6662 | Hiv-1 Protease Inhibitors Wiih LOW Nanomolar Potency |
6663 | Hiv-1 Protease Inhibitors Wiih LOW Nanomolar Potency |
6664 | Hiv-1 Protease Inhibitors Wiih LOW Nanomolar Potency |
32717 | Crystal Structure of the Complex of Resistant Strain of Hiv- 1 Protease(v82a Mutant) With Ritonavir |
30822 | Crystal Structures of a Multidrug-resistant Hiv-1 Protease Reveal an Expanded Active Site Cavity |
30824 | Crystal Structures of a Multidrug-resistant Hiv-1 Protease Reveal an Expanded Active Site Cavity |
30832 | Crystal Structures of a Multidrug-resistant Hiv-1 Protease Reveal an Expanded Active Site Cavity |
2155 | An Orally-bioavailable Hiv-1 Protease Inhibitor Containing an Imidazole-derived Peptide Bond Replacement. Crystallographic and Pharmacokinetic Analysis |
27816 | Crystal Structures of HIV Protease V82a and L90m Mutants Reveal Changes in Indinavir Binding Site |
27817 | Crystal Structures of HIV Protease V82a and L90m Mutants Reveal Changes in Indinavir Binding Site |
27818 | Crystal Structures of HIV Protease V82a and L90m Mutants Reveal Changes in Indinavir Binding Site |
29356 | Comparing the Accumulation of Active Site and Non-active Site Mutations in the Hiv-1 Protease |
29357 | Comparing the Accumulation of Active Site and Non-active Site Mutations in the Hiv-1 Protease |
34058 | Crystal Structure of Hiv-1 Protease Complexed With a Product of Autoproteolysis |
32736 | HIV Protease Wild-type in Complex With Tmc114 Inhibitor |
33412 | The Structural and Thermodynamic Basis for the Binding of Tmc114, a Next-generation Hiv-1 Protease Inhibitor |
33413 | Crystal Structure of Inhibitor Amprenavir in Complex With a Multi-drug Resistant Variant of Hiv-1 Protease (L63pv82ti84v) |
29418 | Crystal Structure of HIV Protease Complexed With Arylsulfonamide Azacyclic Urea |
5483 | HIV Triple Mutant Protease Complexed With Inhibitor Sb203386 |
32250 | Crystal Structure of Ap2v Substrate Variant of Nc-p1 Decamer Peptide in Complex With V82ad25n Hiv-1 Protease Mutant |
32251 | Crystal Structure of Decamer Ncp1 Substrate Peptide in Complex With Wild-type D25n Hiv-1 Protease Variant |
34066 | Wide Open 1.3a Structure of a Multi-drug Resistant Hiv-1 Protease Represents a Novel Drug Target |
74346 | Crystal Structure of a Hiv-1 Protease in Complex With Peptidomimetic Inhibitor Ki2-phe-glu-glu-nh2 |
57578 | Hiv-1 Protease Complex With U095438 [3-[1-(4-bromophenyl) Isobutyl]-4- Hydroxycoumarin |
9368 | Hiv-1 Protease Complexed With the Inhibitor Hoebay 793 Hexagonal Form |
9073 | Hiv-1 Protease Complexed With the Inhibitor Hoebay 793 Orthorhombic Form |
31015 | Hiv-1 Protease in Complex With Fluoro Substituted Diol- Based C2-symmetric Inhibitor |
31016 | Hiv-1 Protease in Complex With Fluoro Substituted Diol- Based C2-symmetric Inhibitor |
34484 | Hiv-1 Protease in Complex With Fluoro Substituted Diol- Based C2-symmetric Inhibitor |
30102 | Hiv-1 Protease in Complex With Fluoro Substituted Diol- Based C2-symmetric Inhibitor |
30471 | Hiv-1 Protease in Complex With Asymmetric Inhibitor, Bea568 |
30472 | Hiv-1 Protease in Complex With Symmetric Inhibitor, Bea450 |
33692 | Hiv-1 Protease in Complex With Pyrrolidinmethanamine |
33693 | Hiv-1 Protease in Complex With Amidhyroxysulfone |
32957 | HIV Protease With Oximinoarylsulfonamide Bound |
74459 | SIV Protease Crystallized With Peptide Product |
74460 | SIV Protease Crystallized With Peptide Product |
32614 | Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic Inhibitor 3 |
32615 | Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic Inhibitor 2 |
52200 | Crystal Structure of the Complex of Mutant Hiv-1 Protease (L63p, A71v, V82t, I84v) With a Hydroxyethylamine Peptidomimetic Inhibitor Boc-phe-psi[r-ch(oh)ch2nh]-phe- Glu-phe-nh2 |
52209 | Crystal Structure of a Complex of Mutant Hiv-1 Protease (A71v, V82t, I84v) With a Hydroxyethylamine Peptidomimetic Inhibitor Boc-phe-psi[r-ch(oh)ch2nh]-phe-glu-phe-nh2 |
74482 | Crystal Structure of a Complex of Mutant Hiv-1 Protease (A71v, V82t, I84v) With a Hydroxyethylamine Peptidomimetic Inhibitor Boc-phe-psi[s-ch(oh)ch2nh]-phe-glu-phe-nh2 |
74485 | Crystal Structure of a Complex of Mutant Hiv-1 Protease (A71v, V82t, I84v) With a Hydroxyethylamine Peptidomimetic Inhibitor |
33905 | HIV Protease With Inhibitor Ab-2 |
33190 | HIV Protease With Scripps Ab-3 Inhibitor |
52289 | Crystal Structure of the Complex of Mutant Hiv-1 Protease (A71v, V82t, I84v) With a Hydroxyethylamine Peptidomimetic Inhibitor Boc-phe-psi[r-ch(oh)ch2nh]-phe-glu-phe-nh2 |
74491 | Crystal Structure of Complex of a Hydroxyethylamine Inhibitor With Hiv-1 Protease at 2.0a Resolution |
74492 | Crystal Structure of Wild Type Hiv-1 Protease (Bru Isolate) With a Hydroxyethylamine Peptidomimetic Inhibitor Boc-phe- Psi[s-ch(oh)ch2nh]-phe-glu-phe-nh2 |
35560 | Crystal Structure of HIV Protease- Metallacarborane Complex |
37496 | High Resolution Structure of Hiv-1 PR With Ts-126 |
35165 | Synthesis and Activity of N-axyl Azacyclic Urea Hiv-1 Protease Inhibitors With High Potency Against Multiple Drug Resistant Viral Strains |
6680 | Structure of a Non-peptide Inhibitor Complexed With Hiv-1 Protease: Developing a Cycle of Structure-based Drug Design |
52495 | Crystal Structure Analysis of Hiv-1 Protease Mutant I84v With a Substrate Analog P2-nc |
52496 | Crystal Structure Analysis of Hiv-1 Protease With a Substrate Analog P2-nc |
37072 | Crystal Structure Analysis of Hiv-1 Protease Mutant V82a With a Substrate Analog Ca-p2 |
86753 | Crystal Structure Analysis of Hiv-1 Protease Mutant V82a With a Substrate Analog P1-p6 |
86754 | Crystal Structure Analysis of Hiv-1 Protease Mutant V82a With a Substrate Analog P2-nc |
37075 | Crystal Structure Analysis of Hiv-1 Protease Mutant V82a With a Substrate Analog P6-pr |
86755 | Crystal Structure Analysis of Hiv-1 Protease With a Substrate Analog P1-p6 |
86756 | Crystal Structure Analysis of Hiv-1 Protease With a Substrate Analog P6-pr |
40657 | Structure of Hiv-1 Protease Bound to Atazanavir |
86768 | Kinetics, Stability, and Structural Changes in High Resolution Crystal Structures of Hiv-1 Protease With Drug Resistant Mutations L24i, I50v, and G73s |
37090 | Kinetics, Stability, and Structural Changes in High Resolution Crystal Structures of Hiv-1 Protease With Drug Resistant Mutations L24i, I50v, and G73s |
86769 | Kinetics, Stability, and Structural Changes in High Resolution Crystal Structures of Hiv-1 Protease With Drug Resistant Mutations L24i, I50v, and G73s |
37092 | Kinetics, Stability, and Structural Changes in High Resolution Crystal Structures of Hiv-1 Protease With Drug Resistant Mutations L24i, I50v, and G73s |
37094 | Kinetics, Stability, and Structural Changes in High Resolution Crystal Structures of Hiv-1 Protease With Drug Resistant Mutations L24i, I50v, and G73s |
52537 | Hiv-1 Protease Nl4-3 in Complex With Inhibitor, Tl-3 |
52538 | Hiv-1 Protease Nl4-3 1X Mutant |
52539 | Hiv-1 Protease Nl4-3 3X Mutant in Complex With Inhibitor, Tl-3 |
52540 | Hiv-1 Protease Nl4-3 6X Mutant |
42560 | Structure of Hiv-1 Protease Mutant Bound to Ritonavir |
42561 | Structure of Hiv-1 Protease Mutant Bound to Indinavir |
36187 | Structure of Hiv1 Protease and Akc4p_133a Complex |
36188 | Structure of Hiv1 Protease and Hh1_173_3a Complex |
9577 | Hiv-1 Protease-inhibitor Complex |
9578 | Hiv-1 Protease-inhibitor Complex |
9579 | Hiv-1 Protease-inhibitor Complex |
9580 | Hiv-1 Protease-inhibitor Complex |
9581 | Hiv-1 Protease-inhibitor Complex |
36732 | Hiv-1 Protease in Complex With Inhibitor Aha455 |
44310 | P1' Extended Hiv-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-state Mimicking Scaffold |
44311 | P1' Extended Hiv-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-state Mimicking Scaffold |
44312 | P1' Extended Hiv-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-state Mimicking Scaffold |
42731 | Substrate Envelope and Drug Resistance: Crystal Structure of R01 in Complex With Wild-type Hiv-1 Protease |
38234 | Hiv-1 Protease Mutant D30n Complexed With Inhibitor Tmc114 |
38235 | Hiv-1 Protease Mutant L90m Complexed With Inhibitor Tmc114 |
38237 | Hiv-1 Protease Mutant I50v Complexed With Inhibitor Tmc114 |
37730 | Wild Type HIV Protease Bound With Gw0385 |
42762 | X-ray Crystal Structure of Hiv-1 Protease T80s Variant in Complex With the Inhibitor Saquinavir Used to Explore the Role of Invariant Thr80 in Hiv-1 Protease Structure, Function, and Viral Infectivity |
42763 | X-ray Crystal Structure of Hiv-1 Protease T80n Variant in Complex With the Inhibitor Saquinavir Used to Explore the Role of Invariant Thr80 in Hiv-1 Protease Structure, Function, and Viral Infectivity |
43759 | Structural Analysis of Asymmetric Inhibitor Bound to the Hiv-1 Protease V82a Mutant |
40850 | Crystal Structure of Wild-type Inactive (D25n) Hiv-1 Protease Complexed With Wild-type Hiv-1 Nc-p1 Substrate |
40851 | Crystal Structure of a Drug-resistant (V82a) Inactive (D25n) Hiv-1 Protease Complexed With Ap2v Variant of Hiv-1 Nc-p1 Substrate |
44395 | X-ray Crystal Structure of Hiv-1 Protease IRM Mutant Complexed With Atazanavir (Bms-232632) |
44396 | X-ray Crystal Structure of Hiv-1 Protease CRM Mutant Complexed With Atazanavir (Bms-232632) |
39342 | Structure of Unliganded Hiv-1 Protease F53l Mutant |
47124 | Structure of HIV Protease 6X Mutant in APO Form |
41020 | Wild-type Hiv-1 Protease in Complex With Potent Inhibitor Grl06579 |
47125 | Structure of HIV Protease Nl4-3 in an Unliganded State |
47126 | Structure of HIV Protease 6X Mutant in Complex With Ab-2 |
41692 | Ultra-high Resolution X-ray Crystal Structure of Hiv-1 Protease V32i Mutant With Tmc114 (Darunavir) Inhibitor |
41693 | Crystal Structure of M46l Mutant of Hiv-1 Protease Complexed With Tmc114 (Darunavir) |
58047 | Three-dimensional Structure of Aspartyl Protease From Human Immunodeficiency Virus Hiv-1 |
43375 | Crystal Structure of Kb-19 Complexed With Wild Type Hiv-1 Protease |
43376 | Crystal Structure of Ad-81 Complexed With Wild Type Hiv-1 Protease |
60050 | Crystal Structure of WT Hiv-1 Protease With Gs-8373 |
58951 | Hiv-1 Protease With Tmc-126 |
58952 | Hiv-1 Protease I84v, L90m With Tmc126 |
58953 | Hiv-1 Protease WT With Gs-8374 |
58954 | Hiv-1 Protease I84v, L90m With Gs-8374 |
41799 | Crystal Structure Analysis of Hiv-1 Protease Mutant V82a With a Potent Non-peptide Inhibitor (Uic-94017) |
41803 | Crystal Structure Analysis of Hiv-1 Protease With a Potent Non-peptide Inhibitor (Uic-94017) |
41804 | Crystal Structure Analysis of Hiv-1 Protease Mutant I84v With a Potent Non-peptide Inhibitor (Uic-94017) |
59054 | Atomic-resolution Crystal Structure of Chemically- Synthesized Hiv-1 Protease Complexed With Inhibitor Jg-365 |
59055 | Atomic-resolution Crystal Structure of Chemically- Synthesized Hiv-1 Protease Complexed With Inhibitor Mvt- 101 |
59062 | Atomic-resolution Crystal Structure of Chemically- Synthesized Hiv-1 Protease in Complex With Jg-365 |
45139 | Crystal Structure Analysis of Hiv-1 Protease Mutant V82a With a Inhibitor Saquinavir |
45140 | Crystal Structure Analysis of Hiv-1 Protease Mutant V82a With a Inhibitor Saquinavir |
45143 | Crystal Structure Analysis of Hiv-1 Protease Mutant I84v With a Inhibitor Saquinavir |
45144 | Crystal Structure Analysis of Hiv-1 Protease Mutant I84v With a Inhibitor Saquinavir |
43491 | Crystal Structure of Hiv1 Protease in Situ Product Complex |
59157 | Structure of Hiv-1 Protease D25n Complexed With Rt-rh Analogue Peptide Gly-ala-asp-ile-phetyr-leu-asp-gly-ala |
59158 | Structure of Hiv-1 Protease D25n Complexed With the Rt-rh Analogue Peptide Gly-ala-glu-val-phetyr-val-asp-gly-ala |
59159 | Structure of Hiv-1 Protease D25n Complexed With the Rt-rh Analogue Peptide Gly-ala-gln-thr-phetyr-val-asp-gly-ala |
43605 | Crystal Structure of Hiv-1 Protease (Q7k) in Complex With Atazanavir |
43606 | Crystal Structure of Hiv-1 Protease (Q7k, I50v) in Complex With Tipranavir |
43607 | Crystal Structure of Hiv-1 Protease (Trm Mutant) in Complex With Tipranavir |
43608 | Crystal Structure of Hiv-1 Protease (Q7k) in Complex With Tipranavir |
43609 | Crystal Structure of Hiv-1 Protease (Q7k) in Complex With Lopinavir |
45722 | Crystal Structure of the Multi-drug Resistant Mutant Subtype B HIV Protease Complexed With Tl-3 Inhibitor |
45723 | Crystal Structure of the Subtype B Wild Type HIV Protease Complexed With Tl-3 Inhibitor |
45724 | Crystal Structure of the Subtype F Wild Type HIV Protease Complexed With Tl-3 Inhibitor |
47218 | APO Wild-type HIV Protease in the Open Conformation |
46591 | Crystal Structure of Hiv-1 Protease (Q7k, L33i, L63i ) in Complex With Kni-10075 |
46592 | Crystal Structure of Hiv-1 Protease (Q7k, L33i, L63i) in Complex With Kni-10033 |
63765 | Hiv-1 Protease in Complex With a Pyrrolidine-based Inhibitor |
46678 | Crystal Structure of Wild Type Hiv-1 Protease in Complex With Carb- Ad37 |
46679 | Crystal Structure of Wild Type Hiv-1 Protease in Complex With Carb-kb45 |
63769 | Hiv-1 Protease in Complex With a Amino Decorated Pyrrolidine-based Inhibitor |
63770 | Hiv-1 Protease in Complex With a Carbamoyl Decorated Pyrrolidine-based Inhibitor |
62668 | Hiv-1 PR Mutant in Complex With Nelfinavir |
62669 | Hiv-1 PR Mutant in Complex With Nelfinavir |
60188 | Crystal Structure of Lysine Sulfonamide Inhibitor Reveals the Displacement of the Conserved Flap Water Molecule in Hiv-1 Protease |
59383 | Crystal Structure of Kb73 Bound to Hiv-1 Protease |
59384 | Crystal Structure of Kk44 Bound to Hiv-1 Protease |
59385 | Crystal Structure of Lopinavir Bound to Wild Type Hiv-1 Protease |
62673 | Hiv-1 PR Mutant in Complex With Nelfinavir |
62674 | Hiv-1 PR Mutant in Complex With Nelfinavir |
65163 | Hiv-1 PR Mutant in Complex With Nelfinavir |
63913 | Hiv-1 Protease Mutant D30n With Potent Antiviral Inhibitor Grl-98065 |
63914 | Hiv-1 Protease Mutant I50v With Potent Antiviral Inhibitor Grl-98065 |
63915 | Hiv-1 Protease Mutant V82a With Potent Antiviral Inhibitor Grl-98065 |
63916 | Hiv-1 Protease Mutant I84v With Potent Antiviral Inhibitor Grl-98065 |
65545 | The Influence of I47a Mutation on Reduced Susceptibility to the Protease Inhibitor Lopinavir |
63917 | Crystal Structure of Protease Inhibitor, Mit-1-ac86 in Complex With Wild Type Hiv-1 Protease |
63918 | Crystal Structure of Protease Inhibitor, Mit-1-ac87 in Complex With Wild Type Hiv-1 Protease |
63919 | Crystal Structure of Protease Inhibitor, Mit-1-kk80 in Complex With Wild Type Hiv-1 Protease |
63920 | Crystal Structure of Protease Inhibitor, Mit-1-kk81 in Complex With Wild Type Hiv-1 Protease |
63921 | Crystal Structure of Protease Inhibitor, Mit-2-ad94 in Complex With Wild Type Hiv-1 Protease |
63922 | Crystal Structure of Protease Inhibitor, Mit-2-ad93 in Complex With Wild Type Hiv-1 Protease |
63923 | Crystal Structure of Protease Inhibitor, Mit-2-kc08 in Complex With Wild Type Hiv-1 Protease |
63924 | Crystal Structure of Protease Inhibitor, Mit-2-kb98 in Complex With Wild Type Hiv-1 Protease |
63925 | Crystal Structure of Protease Inhibitor, Mit-2-ad86 in Complex With Wild Type Hiv-1 Protease |
65553 | Crystal Structure of Hiv-1 Protease Complexed With Pl-100 |
63777 | Hiv-1 Protease in Complex With a Multiple Decorated Pyrrolidine-based Inhibitor |
63778 | Hiv-1 Protease in Complex With a Iodo Decorated Pyrrolidine- Based Inhibitor |
63779 | Hiv-1 Protease in Complex With a Chloro Decorated Pyrrolidine-based Inhibitor |
66402 | I84v Hiv-1 Protease Mutant in Complex With a Carbamoyl Decorated Pyrrolidine-based Inhibitor |
66403 | I50v Hiv-1 Protease Mutant in Complex With a Carbamoyl Decorated Pyrrolidine-based Inhibitor |
66404 | I84v Hiv-1 Protease in Complex With a Amino Decorated Pyrrolidine-based Inhibitor |
66548 | I50v Hiv-1 Protease in Complex With an Amino Decorated Pyrrolidine- Based Inhibitor |
60824 | Crystal Structure Analysis of Hiv-1 Subtype C Protease Complexed With Indinavir |
60825 | Crystal Structure Analysis of Hiv-1 Subtype C Protease Complexed With Nelfinavir |
65689 | Structural Analysis of the Unbound Form of Hiv-1 Subtype C Protease |
65815 | Hiv-1 PR Resistant Mutant + LPV |
65816 | Hiv-1 PR Resistant Mutant + LPV |
4714 | Hiv-1 Protease Complex With U100313 ([3-[[3-[cyclopropyl [4-hydroxy- 2oxo-6-[1-(phenylmethyl)propyl]-2h-pyran-3-yl] Methyl]phenyl]amino]- 3-oxo-propyl]carbamic Acid Tert-butyl Ester) |
64505 | Two-carbon-elongated Hiv-1 Protease Inhibitors With a Tertiary-alcohol-containing Transition-state Mimic |
64506 | Two-carbon-elongated Hiv-1 Protease Inhibitors With a Tertiary-alcohol-containing Transition-state Mimic |
78684 | Hiv-1 Protease Inhibitors Containing a Tertiary Alcohol in the Transition-state Mimic With Improved Cell-based Antiviral Activity |
78685 | Hiv-1 Protease Inhibitors Containing a Tertiary Alcohol in the Transition-state Mimic With Improved Cell-based Antiviral Activity |
63959 | Wild Type Hiv-1 Protease With Potent Antiviral Inhibitor Grl-98065 |
65219 | The Influence of I47a Mutation on Reduced Susceptibility to the Protease Inhibitor Lopinavir |
69386 | Hiv-1 Protease in Complex With a Dimethylallyl Decorated Pyrrolidine Based Inhibitor (Hexagonal Space Group) |
70349 | Structure of Hiv-1 Protease in Complex With Potent Inhibitor Kni-272 Determined by Neutron Crystallography |
80389 | Crystal Structure of Hiv-1 Protease Complexed With Kni-1689 |
6394 | a NEW Class of Hiv-1 Protease Inhibitor: the Crystallographic Structure, Inhibition and Chemical Synthesis of an Aminimide Peptide Isostere |
61421 | Hiv-1 Protease Complexed With Gem-diol-amine Tetrahedral Intermediate Nlltqi |
61422 | Hiv-1 Protease Mutant I54v Complexed With Gem-diol-amine Intermediate Nlltqi |
66440 | I84v Hiv-1 Protease in Complex With a Pyrrolidine Diester |
66441 | Hiv-1 Protease in Complex With a Isobutyl Decorated Oligoamine |
66442 | Hiv-1 Protease in Complex With a Benzyl Decorated Oligoamine |
68388 | Hiv-1 Protease in Complex With a Three Armed Pyrrolidine Derivative |
63520 | Cystal Structure of Hiv-1 Active Site Mutant D25n and P2-nc Analog Inhibitor |
63521 | Cystal Structure of Hiv-1 Active Site Mutant D25n and Inhibitor Darunavir |
63305 | Crystal Structures of Highly Constrained Substrate and Hydrolysis Products Bound to Hiv-1 Protease. Implications for Catalytic Mechanism |
63306 | Crystal Structures of Highly Constrained Substrate and Hydrolysis Products Bound to Hiv-1 Protease. Implications for Catalytic Mechanism |
70361 | Hiv-1 Protease in Complex With a Dimethylallyl Decorated Pyrrolidine Based Inhibitor (Orthorombic Space Group) |
64714 | Effect of Flap Mutations on Structure of Hiv-1 Protease and Inhibition by Saquinavir and Darunavir |
64715 | Crystal Structure of Hiv-1 Mutant I50v and Inhibitor Saquinavira |
64794 | Crystal Structure of Hiv-1 Mutant I54m and Inhibitor Saquinavir |
64718 | Crystal Structure of Hiv-1 Mutant I54v and Inhibitor Saquina |
64719 | Crystal Structure of Hiv-1 Mutant I54m and Inhibitor Darunavir |
64720 | Crystal Structure of Hiv-1 Mutant I54v and Inhibitor Darunavia |
65416 | Crystal Structure of Hiv-1 Crf01_ae in Complex With the Substrate P1-p6 |
67036 | Wild Type Hiv-1 Protease With Potent Antiviral Inhibitor Grl-0255a |
72588 | Wild Type Hiv-1 Protease With Potent Antiviral Inhibitor Grl-0105a |
76405 | Crystal Structure of the Inhibitor Amprenavir (Apv) in Complex With a Multi-drug Resistant Hiv-1 Protease Variant (L10ig48vi54vv64iv82a)refer: Flap+ in Citation |
76406 | Crystal Structure of Inhibitor Saquinavir (Sqv) in Complex With Multi- Drug Resistant Hiv-1 Protease (L63pv82ti84v) (Referred to as ACT in Paper) |
76407 | Crystal Structure of the Inhibitor Darunavir (Drv) in Complex With a Multi-drug Resistant Hiv-1 Protease Variant (L10fg48vi54vv64iv82a) (Refer: Flap+ in Citation.) |
76408 | Crystal Structure of the Wild Type Hiv-1 Protease With the Inhibitor, Amprenavir |
76409 | Crystal Structure of the Inhibitor Atazanavir (Atv) in Complex With a Multi-drug Resistance Hiv-1 Protease Variant (L10ig48vi54vv64iv82a) Refer: Flap+ in Citation |
76410 | Crystal Structure of the Wild-type Hiv-1 Protease With the Inhibitor, Nelfinavir |
76411 | Crystal Structure of Wild-type HIV Protease in Complex With the Inhibitor, Atazanavir |
76412 | Crystal Structure of the Inhibitor Nelfinavir (Nfv) in Complex With a Multi-drug Resistant Hiv-1 Protease Variant (L10ig48vi54vv64iv82a) (Refer: Flap+ in Citation) |
76413 | Crystal Structure of Wild-type HIV Protease in Complex With the Inhibitor, Atazanavir |
76414 | Crystal Structure of Inhibitor Saquinavir (Sqv) Complexed With the Multidrug Hiv-1 Protease Variant L63pv82ti84v |
76415 | Crystal Structure of Nelfinavir (Nfv) Complexed With a Multidrug Variant (Act) (V82ti84v) of Hiv-1 Protease |
76416 | Crystal Structure of Atazanavir (Atv) in Complex With a Multidrug Hiv- 1 Protease (V82ti84v) |
76417 | Crystal Structure of Amprenavir (Apv) in Complex With a Drug Resistant Hiv-1 Protease Variant (I50la71v) |
76418 | Crystal Structure of Atazanavir (Atv) in Complex With I50la71v Drug- Resistant Hiv-1 Protease |
76419 | Crystal Structure of I50la71v Mutant of Hiv-1 Protease in Complex With Inhibitor Darunavir |
70417 | Structure of Hiv-1 Protease in Complex With Potent Inhibitor Kni-272 Determined by High Resolution X-ray Crystallography |
72913 | HIV Protease Inhibitors With Pseudo-symmetric Cores |
72914 | HIV Protease, Pseudo-symmetric Inhibitors |
72915 | HIV Protease, Pseudo-symmetric Inhibitors |
80631 | Crystal Structure of Protease Inhibitor, Kb60 in Complex With Wild Type Hiv-1 Protease |
80632 | Crystal Structure of Protease Inhibitor, Kb62 in Complex With Wild Type Hiv-1 Protease |
80633 | Crystal Structure of Protease Inhibitor, Ad78 in Complex With Wild Type Hiv-1 Protease |
73369 | Crystal Structure of Wild Type Hiv-1 Protease With Novel P1'-ligand Grl-02031 |
58324 | Conserved Folding in Retroviral Proteases. Crystal Structure of a Synthetic Hiv-1 Protease |
77049 | Crystal Structure of Wild Type Hiv-1 Protease With Macrocyclic Inhibitor Grl-0216a |
77050 | Co-crystal Structure of Hiv-1 Protease Bound to a Mutant Resistant Inhibitor Uic-98038 |
78436 | Crystal Structure of a Metallacarborane Inhibitor Bound to HIV Protease |
80460 | Crystal Structure of Uncomplexed Hiv_1 Protease Subtype a |
78620 | Hiv-1 Protease Mutant G86a With Symmetric Inhibitor Dmp323 |
78621 | Hiv-1 Protease Mutant G86a With Darunavir |
78622 | Hiv-1 Protease Mutant G86s With Darunavir |
82614 | NEW Crystal Form of Hiv-1 Proteasesaquinavir Structure Reveals Carbamylation of N-terminal Proline |
80488 | Crystal Structure of Hiv-1 Protease (Q7k, L33i, L63i) in Complex With Kni-10006 |
80811 | Crystal Structure of Hiv-1 Protease (Q7k, L33i, L63i) in Complex With Kni-10074 |
80489 | Crystal Structure of Hiv-1 Protease (Q7k, L33i, L63i) in Complex With Kni-10265 |
80269 | HIV Protease With Fragment 4D9 Bound |
80273 | HIV Protease (Pr) With Inhibitor Tl-3 and Fragment HIT 4D9 by Soaking |
80274 | HIV Protease (Pr) With Inhibitor Tl-3 Bound, and Dmsos in EXO Site |
80275 | HIV Protease (Pr) Dimer With Inhibitor Tl-3 Bound and Fragment 1F1 in the Outsidetop of Flap |
80276 | HIV Protease (Pr) Dimer With Inhibitor Tl-3 Bound and Fragment 2F4 in the Outside/top of Flap |
84004 | Crystal Structure of Hiv-1 Crf01_ae Protease in Complex With Darunavir |
84005 | Crystal Structure of a Nelfinavir Resistant Hiv-1 Crf01_ae Protease Variant (N88s) in Complex With the Protease Inhibitor Darunavir |
84006 | Structure of Nelfinavir-resistant Hiv-1 Protease (D30nn88d) in Complex With Darunavir |
83066 | HIV Protease Complexed With Compound 10B |
89829 | X-ray Snapshot of Hiv-1 Protease in Action: Observation of Tetrahedral Intermediate and ITS Sihb With Catalytic Aspartate |
86104 | Crystal Structure of Hiv-1 Protease Inhibitor Kc53 in Complex With Wild-type Protease |
86105 | Crystal Structure of Hiv-1 Protease Inhibitor, Kc32 Complexed With Wild-type Protease |
84429 | Wild Type Hiv-1 Protease With Antiviral Drug Amprenavir |
84430 | Crystal Structure of Hiv-1 Protease Mutant V32i With Antiviral Drug Amprenavir |
84431 | Crystal Structure of Hiv-1 Protease Mutant I50v With Antiviral Drug Amprenavir |
84432 | Crystal Structure of Hiv-1 Protease Mutant I54m With Antiviral Drug Amprenavir |
84433 | Crystal Structure of Hiv-1 Protease Mutant I84v With Antiviral Drug Amprenavir |
84435 | Crystal Structure of Hiv-1 Protease Mutant I54v With Antiviral Drug Amprenavir |
84436 | Crystal Structure of Hiv-1 Protease Mutant L90m With Antiviral Drug Amprenavir |
85080 | Crystal Structure of Wild-type Hiv-1 Protease With NEW Oxatricyclic Designed Inhibitor Grl-0519a |
89684 | Crystal Structures of Multidrug-resistant Clinical Isolate 769 Hiv-1 Protease Variants |
89685 | Crystal Structures of Multidrug-resistant Clinical Isolate 769 Hiv-1 Protease Variants |
89686 | Crystal Structures of Multidrug-resistant Clinical Isolate 769 Hiv-1 Protease Variants |
89529 | Mdr769 Hiv-1 Protease Complexed With Maca Hepta-peptide |
89530 | Mdr769 Hiv-1 Protease Complexed With Rtrh Hepta-peptide |
89531 | Mdr769 Hiv-1 Protease Complexed With Rhin Hepta-peptide |
89532 | Mdr769 Hiv-1 Protease Complexed With Prrt Hepta-peptide |
89533 | Mdr769 Hiv-1 Protease Complexed With Tfpr Hepta-peptide |
89534 | Mdr769 Hiv-1 Protease Complexed With P1p6 Hepta-peptide |
89535 | Mdr769 Hiv-1 Protease Complexed With Ncp1 Hepta-peptide |
89536 | Mdr769 Hiv-1 Protease Complexed With P2nc Hepta-peptide |
89537 | Mdr769 Hiv-1 Protease Complexed With Cap2 Hepta-peptide |
86145 | Wild Type Hiv-1 Protease With Antiviral Drug Saquinavir |
88541 | Crystal Structure of Hiv-1 L76v Protease in Complex With the Protease Inhibitor Darunavir |
58353 | X-ray Analysis of Hiv-1 Proteinase at 2.7 Angstroms Resolution Confirms Structural Homology Among Retroviral Enzymes |
89695 | Crystal Structures of Multidrug-resistant Clinical Isolate 769 Hiv-1 Protease Variants |
90013 | Hiv-1 Protease Mutant L76v With Darunavir |
90014 | Hiv-1 Protease Mutant L76v Complexed With Saquinavir |
12235 | Structural Studies of HIV and FIV Proteases Complexed Withan Efficient Inhibitor of FIV PR |
54728 | Structure of Complex of Synthetic Hiv-1 Protease With a Stubtrate-based Inhibitor at 2.3 Angstroms Resolution |
3200 | X-ray Crystal Structure of the HIV Protease Complex With L- 700,417, an Inhibitor With Pseudo C2 Symmetry |
54778 | Crystallographic Analysis of a Complex Between Human Immunodeficiency Virus Type 1 Protease and Acetyl- Pepstatin at 2.0-angstroms Resolution |
54817 | X-ray Crystallographic Structure of a Complex Between a Synthetic Protease of Human Immunodeficiency Virus 1 and a Substrate-based Hydroxyethylamine Inhibitor |
5757 | Hiv-1 Proteaseu101935 Complex |
3407 | Structure at 2.5-angstroms Resolution of Chemically Synthesized Human Immunodeficiency Virus Type 1 Protease Complexed With a Hydroxyethylene-based Inhibitor |
54880 | Design, Activity and 2.8 Angstroms Crystal Structure of a C2 Symmetric Inhibitor Complexed to Hiv-1 Protease |